US-based Merck & Co, Inc has decided to acquire and merge Schering-Plough Corporation in a stock and cash transaction for total consideration of $41.1 billion. The transaction will be structured as a 'reverse merger' in which Schering-Plough, renamed Merck, will continue as the surviving public corporation.
The details can be read here.
No comments:
Post a Comment